Mustimbo Roberts

1.5k total citations
23 papers, 592 citations indexed

About

Mustimbo Roberts is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Transplantation. According to data from OpenAlex, Mustimbo Roberts has authored 23 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Transplantation. Recurrent topics in Mustimbo Roberts's work include Renal Transplantation Outcomes and Treatments (5 papers), Advanced Breast Cancer Therapies (3 papers) and Cancer Treatment and Pharmacology (3 papers). Mustimbo Roberts is often cited by papers focused on Renal Transplantation Outcomes and Treatments (5 papers), Advanced Breast Cancer Therapies (3 papers) and Cancer Treatment and Pharmacology (3 papers). Mustimbo Roberts collaborates with scholars based in United States, United Kingdom and Spain. Mustimbo Roberts's co-authors include Robert Townsend, Robert A. Bray, Howard M. Gebel, Christian P. Larsen, V Wright, Alan Hill, Helen E. Raybould, G.J. Dockray, Martin S. Polinsky and H.-U. Meier-Kriesche and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Mustimbo Roberts

23 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mustimbo Roberts United States 13 201 197 171 109 88 23 592
E.M. Van Den Berg‐Loonen Netherlands 19 191 1.0× 560 2.8× 141 0.8× 159 1.5× 107 1.2× 44 984
Maciej Zieliński Poland 16 212 1.1× 353 1.8× 225 1.3× 17 0.2× 51 0.6× 68 872
T. C. Pearson United Kingdom 10 159 0.8× 205 1.0× 129 0.8× 22 0.2× 55 0.6× 19 497
Lechler Ri United Kingdom 11 75 0.4× 259 1.3× 92 0.5× 26 0.2× 102 1.2× 30 579
D.-D. Lee Taiwan 8 32 0.2× 123 0.6× 55 0.3× 64 0.6× 126 1.4× 8 597
Joshua H. Wolf United States 13 112 0.6× 42 0.2× 280 1.6× 29 0.3× 79 0.9× 44 771
Midas Seyda Germany 8 157 0.8× 118 0.6× 136 0.8× 10 0.1× 75 0.9× 10 439
F Bouissou France 12 95 0.5× 318 1.6× 124 0.7× 40 0.4× 38 0.4× 36 781
Junlong Zhang China 16 39 0.2× 131 0.7× 45 0.3× 107 1.0× 126 1.4× 48 754
Marek Durlik Poland 15 111 0.6× 91 0.5× 319 1.9× 13 0.1× 90 1.0× 94 780

Countries citing papers authored by Mustimbo Roberts

Since Specialization
Citations

This map shows the geographic impact of Mustimbo Roberts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mustimbo Roberts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mustimbo Roberts more than expected).

Fields of papers citing papers by Mustimbo Roberts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mustimbo Roberts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mustimbo Roberts. The network helps show where Mustimbo Roberts may publish in the future.

Co-authorship network of co-authors of Mustimbo Roberts

This figure shows the co-authorship network connecting the top 25 collaborators of Mustimbo Roberts. A scholar is included among the top collaborators of Mustimbo Roberts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mustimbo Roberts. Mustimbo Roberts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Argiris, Athanassios, Kevin J. Harrington, Makoto Tahara, et al.. (2021). LBA36 Nivolumab (N) + ipilimumab (I) vs EXTREME as first-line (1L) treatment (tx) for recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): Final results of CheckMate 651. Annals of Oncology. 32. S1310–S1311. 21 indexed citations
2.
Tolaney, Sara M., Guy Jérusalem, Roberto Salgado, et al.. (2020). 133TiP A phase II trial of nivolumab + palbociclib + anastrozole in postmenopausal women with ER+/HER2– primary breast cancer: CheckMate 7A8. Annals of Oncology. 31. S60–S60. 2 indexed citations
3.
Tolaney, Sara M., Guy Jérusalem, Roberto Salgado, et al.. (2020). A phase II trial of nivolumab (NIVO) + palbociclib (PAL) + anastrozole (ANA) in postmenopausal women and men with estrogen receptor (ER)+/human epidermal growth factor 2 (HER2)- primary breast cancer (BC): CheckMate 7A8.. Journal of Clinical Oncology. 38(15_suppl). TPS1105–TPS1105. 4 indexed citations
4.
Li, Bin, Lloye M. Dillon, Jennifer L. Jones, et al.. (2020). A comparative study of PD-L1 IHC assays using immune cell scoring and CPS in breast cancer.. Journal of Clinical Oncology. 38(15_suppl). e15262–e15262. 3 indexed citations
5.
Moudgil, Asha, Vikas R. Dharnidharka, Daniel I. Feig, et al.. (2018). Phase I study of single-dose pharmacokinetics and pharmacodynamics of belatacept in adolescent kidney transplant recipients. American Journal of Transplantation. 19(4). 1218–1223. 13 indexed citations
6.
Everly, Matthew J., Mustimbo Roberts, Robert Townsend, Robert A. Bray, & Howard M. Gebel. (2018). Comparison of de novo IgM and IgG anti-HLA DSAs between belatacept- and calcineurin-treated patients: An analysis of the BENEFIT and BENEFIT-EXT trial cohorts. American Journal of Transplantation. 18(9). 2305–2313. 28 indexed citations
7.
Bray, Robert A., Howard M. Gebel, Robert Townsend, et al.. (2018). De novo donor-specific antibodies in belatacept-treated vs cyclosporine-treated kidney-transplant recipients: Post hoc analyses of the randomized phase III BENEFIT and BENEFIT-EXT studies. American Journal of Transplantation. 18(7). 1783–1789. 98 indexed citations
8.
Bray, Robert A., Howard M. Gebel, Robert Townsend, et al.. (2018). Posttransplant reduction in preexisting donor-specific antibody levels after belatacept- versus cyclosporine-based immunosuppression: Post hoc analyses of BENEFIT and BENEFIT-EXT. American Journal of Transplantation. 18(7). 1774–1782. 43 indexed citations
9.
Mathews, David V., Michael Lowe, Cynthia Breeden, et al.. (2017). Belatacept-Resistant Rejection Is Associated With CD28+ Memory CD8 T Cells. American Journal of Transplantation. 17(9). 2285–2299. 50 indexed citations
10.
Bihlet, Asger Reinstrup, M.A. Karsdal, Jannie Marie Bülow Sand, et al.. (2017). Biomarkers of extracellular matrix turnover are associated with emphysema and eosinophilic-bronchitis in COPD. Respiratory Research. 18(1). 22–22. 58 indexed citations
11.
Roberts, Mustimbo, Brandon W. Higgs, Philip Z. Brohawn, et al.. (2015). CD4+ T-Cell Profiles and Peripheral Blood Ex-Vivo Responses to T-Cell Directed Stimulation Delineate COPD Phenotypes. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 2(4). 268–280. 12 indexed citations
12.
Roberts, Mustimbo, Denise A. Kaminski, Scott A. Jenks, et al.. (2014). Primary Sjögren's Syndrome Is Characterized by Distinct Phenotypic and Transcriptional Profiles of IgD+ Unswitched Memory B Cells. Arthritis & Rheumatology. 66(9). 2558–2569. 40 indexed citations
13.
Punter, Martin, et al.. (2011). 02 Successful withdrawal of 3,4--Diaminopyridine: a report on six patients with Lambert Eaton Myasthenic Syndrome. Journal of Neurology Neurosurgery & Psychiatry. 82(3). e1–e1. 1 indexed citations
14.
Hefferon, Timothy, et al.. (2009). Multiple Endocrine Neoplasia Type 1 (MEN1) Syndrome -- Cancer Syndromes. 4 indexed citations
15.
Reeve, Roy, et al.. (2005). Influenza vaccine-induced rhabdomyolysis leading to acute renal transplant dysfunction. Nephrology Dialysis Transplantation. 21(2). 530–531. 24 indexed citations
16.
Raybould, Helen E., Mustimbo Roberts, & G.J. Dockray. (1987). Reflex decreases in intragastric pressure in response to cholecystokinin in rats. American Journal of Physiology-Gastrointestinal and Liver Physiology. 253(2). G165–G170. 60 indexed citations
17.
Raybould, Helen E., Mustimbo Roberts, & G.J. Dockray. (1986). Reflex gastric relaxation evoked by cholecystokinin in the rat. Regulatory Peptides. 15(2). 190–190. 1 indexed citations
18.
Roberts, Mustimbo, et al.. (1976). Psoriatic arthritis. Follow-up study.. Annals of the Rheumatic Diseases. 35(3). 206–212. 85 indexed citations
19.
Roberts, Mustimbo, et al.. (1964). Pituitary-adrenal stimulation induced by lethal doses of 1-aminocyclopentanecarboxylic acid. Cellular and Molecular Life Sciences. 20(12). 707–707. 2 indexed citations
20.
Shankman, S., et al.. (1962). Synthesis of Peptides of 1-Aminocyclopentanecarboxylic Acid. Journal of Medicinal Chemistry. 5(1). 42–49. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E.M. Van Den Berg‐Loonen Breakdown of academic impact, for papers by Maciej Zieliński Breakdown of academic impact, for papers by T. C. Pearson Breakdown of academic impact, for papers by Lechler Ri Breakdown of academic impact, for papers by D.-D. Lee Breakdown of academic impact, for papers by Joshua H. Wolf Breakdown of academic impact, for papers by Midas Seyda Breakdown of academic impact, for papers by F Bouissou Breakdown of academic impact, for papers by Junlong Zhang Breakdown of academic impact, for papers by Marek Durlik
Rankless by CCL
2026